Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : MAN-01
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Recipient : Q BioMed
Deal Size : $42.3 million
Deal Type : Agreement
Details : By utilizing MRI’s internal pro-forma revenue projections for 2023 & 2024 and comparable market transactions, MRI’s drug development pipeline including MAN-01 and companion diagnostics, are estimated to achieve a net present value.
Brand Name : MAN-01
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 14, 2022
Lead Product(s) : MAN-01
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Recipient : Q BioMed
Deal Size : $42.3 million
Deal Type : Agreement
Lead Product(s) : MAN-19
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : Q BioMed
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : MAN-19 therapeutic is a recombinant fusion protein that treats the patient, instead of targeting the virus. It is not a cure for COVID, but it strengthens a patient's blood vessels and protects them against ARDS, breathing problems, sepsis and other infe...
Brand Name : MAN-19
Molecule Type : Small molecule
Upfront Cash : Not Applicable
September 22, 2021
Lead Product(s) : MAN-19
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : Q BioMed
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Platform has been awarded grants from Canada and Europe for its development of therapeutics; additional grant submitted to the STTR program administered by the U.S. National Institutes of Health.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Not Applicable
February 20, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?